American Pharmaceutical News In Review

View online

Forward to a friend | Facebook | Twitter

June 22, 2021

Newsletter Sponsor

Formulation - a game-changer

Whether it’s an innovative therapeutic modality or a supplier falling out of regulatory compliance, disruptions come in known challenges and unexpected obstacles. Control is what allows you to decide the shape that disruption will take. With a portfolio of over 400 excipients, formulation technologies, and global regulatory expertise, MilliporeSigma is changing the rules on disruption, giving you greater control in your formulations.

	Industry News

Stop Using Innova SARS-CoV-2 Antigen Rapid Qualitative Test - FDA MedWatch
The U.S. FDA issued a safety communication warning the public to stop using the Innova SARS-CoV-2 ... read more »

Changes to the Mavyret Product Label for Pediatrics
FDA approved Mavyret (glecaprevir and pibrentasvir) oral pellets (100mg/40mg) for the treatment of ... read more »

iTeos Therapeutics and GSK Announce Development and Commercialization Collaboration for Novel Next-Gen Immuno-Oncology Treatment
iTeos Therapeutics and GlaxoSmithKline plc agree to co-develop and co-commercialize EOS-448, an anti... read more »

Avenue Therapeutics Receives Complete Response Letter from the FDA for IV Tramadol
Avenue Therapeutics Inc, a company focused on the development of intravenous (“IV”) tramadol for the... read more »

	Infographic

Measuring Total Organic Carbon (TOC) Continuously in Real-Time
Total Organic Carbon (TOC) control is essential in the production of high purity pharmaceutical water. Whether you are upgrading your current system ... read more »

	Featured Articles

Drug Development in Oncology in the Era of Precision Medicine Cancer research is complex: trials require specific design expertise and often include biomarker and companion diagnostics, and failure rates tend to ... read more »

Vaccines and Therapeutics for COVID-19 – How Can Understanding SARS-CoV-2 Glycosylation Lead to Pharmaceutical Advances? The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than 160 million people worldwide. ... read more »

	Featured Video

On-Demand Webinar: High-Purity Albumin Improves Biopharmaceutical Formulations and Performance
In this webinar you’ll learn: optimizing final formulation of drug products with albumin; how to avoid the variable nature of albumin’s structure, how... watch »

On-Demand Webinar: Building Cleanrooms At Warp Speed
In this webinar, you’ll learn about the additional challenges COVID presented to already compressed timelines and the strategies AES utilized to ... watch »

	Featured Whitepaper

eBook: Focus On Drug Development: Solutions to Product Formulation and Development Challenges
eBook covers a wide variety of topics that focus on some of the most difficult product formulation and development challenges. Articles present solutions to working with many of the most ... read more »

	Events

Microscopy & Microanalysis 2021
Virtual – 08/01/2021
Brought to you by the Microscopy Society of America (MSA) and the Microanalysis Society (MAS), the M&M conference is the largest scientific meeting ... event details »

Webinar: Drug Product/Protein Concentration using the CTech FlowVPE System
Online – 06/22/2021
Raf De Dier holds a Master’s degree in Chemical Engineering and obtained his PhD at the University of Leuven in Belgium and ETH Zürich in Switzerland.... event details »

This information is being brought to you because you are a subscriber to
American Pharmaceutical Review. To ensure delivery to your inbox,
please add newsletters@americanpharmaceuticalreview.com to your address book.

Manage your Subscription | Unsubscribe | Contact American Pharmaceutical Review

American Pharmaceutical Review
164 Townsend St. Unit 2
San Francisco, CA 94107 USA